ANGIODYNAMICS INC (ANGO)

Company Profile

AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 815 full-time employees. The company went IPO on 2004-05-27. The firm is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options. The company is engaged in manufacturing, developing, and selling medical devices for vascular access, peripheral vascular disease, and oncology on a global basis. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, midlines, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and 400 Micron Perforator & Accessory Vein Ablation Kit (PVAK). Its vascular interventions include Syntrax Support Catheter, AlphaVac, SpeedLyser PRO Infusion System. Its ports include Xcela Plus Ports and Conventional Ports.

Company Info

ANGIODYNAMICS INC

14 Plaza Dr

Latham NEW YORK 12110

P: 15187981215

CEO: James C. Clemmer

Employees: 815

Website: https://www.angiodynamics.com/